Condensed Consolidated Balance Sheets - USD ($) $ in Millions	Mar. 31, 2026	Jun. 30, 2025
Current assets
Cash and cash equivalents	$ 1,187	$ 167
Receivables, net	671	821
Inventories, net	588	523
Prepaid expenses and other current assets	205	97
Total current assets	2,651	1,608
Property, plant and equipment, net of accumulated depreciation and amortization of $3,044 and $2,911, respectively	1,235	1,267
Operating lease right-of-use assets	355	333
Goodwill	1,229	1,229
Trademarks, net	502	502
Other intangible assets, net	49	64
Other assets	415	558
Total assets	6,436	5,561
Current liabilities
Notes and loans payable	1,591	4
Current operating lease liabilities	85	87
Accounts payable and accrued liabilities	1,479	1,828
Total current liabilities	3,155	1,919
Long-term debt	2,487	2,484
Long-term operating lease liabilities	323	305
Other liabilities	356	351
Deferred income taxes	23	20
Total liabilities	6,344	5,079
Commitments and contingencies
Stockholders’ equity
Preferred stock: $1.00 par value; 5,000,000 shares authorized; none issued or outstanding	0	0
Common stock: $1.00 par value; 750,000,000 shares authorized; 130,741,461 shares issued as of March 31, 2026 and June 30, 2025; and 120,920,243 and 122,694,263 shares outstanding as of March 31, 2026 and June 30, 2025, respectively	131	131
Additional paid-in capital	1,315	1,319
Retained earnings	223	432
Treasury stock, at cost: 9,821,218 and 8,047,198 shares as of March 31, 2026 and June 30, 2025, respectively	(1,584)	(1,404)
Accumulated other comprehensive net (loss) income	(152)	(157)
Total Clorox stockholders’ (deficit) equity	(67)	321
Noncontrolling interests	159	161
Total stockholders’ equity	92	482
Total liabilities and stockholders’ equity	$ 6,436	$ 5,561